ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,625
0,10%
Bitcoin
59 089,93
1,46%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evelo Biosciences Inc (EVLO)

  7. Evelo Biosciences Inc (EVLO) Actualités

EVLO Evelo Biosciences Inc

0,3165
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Evelo Biosciences Inc EVLO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,3165 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,3165 0,3165
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/1/202423:30EDGAR2Form 15-12G - Securities registration termination [Section..
26/1/202423:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/1/202423:27EDGAR2Form POS AM - Post-Effective amendments for registration..
26/1/202423:26EDGAR2Form 8-K - Current report
12/12/202313:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/12/202313:42EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202312:04EDGAR2Form 8-K - Current report
01/12/202313:11EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202312:44EDGAR2Form 8-K - Current report
09/11/202323:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202302:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202302:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202323:24EDGAR2Form 8-K - Current report
17/10/202313:05EDGAR2Form 8-K - Current report
17/10/202313:00GLOBEEvelo Biosciences Announces Top-Line Results From its Phase..
14/9/202302:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202302:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202302:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/202313:43EDGAR2Form 8-K - Current report
18/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14/8/202314:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:42EDGAR2Form 8-K - Current report
14/8/202313:30GLOBEEvelo Biosciences Announces Second Quarter Financial Results..
10/8/202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202302:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:21EDGAR2Form 8-K - Current report
18/7/202313:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
12/7/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/7/202313:55EDGAR2Form 8-K - Current report
12/7/202313:30GLOBEEvelo Biosciences Closes $25.5 Million Private Placement
10/7/202313:36EDGAR2Form 8-K - Current report
10/7/202313:30GLOBEEvelo Biosciences Announces $25.5 Million Private Placement
07/7/202322:06EDGAR2Form 8-K - Current report
29/6/202323:10EDGAR2Form 8-K - Current report
29/6/202315:00GLOBEEvelo Biosciences Announces Reverse Stock Split Effective
16/5/202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Dernières Valeurs Consultées

NASDAQ
EVLO
Evelo Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés